Home > Press > Lumera Receives Order and Enters Into Agreement with Lockheed Martin
Lumera Corporation (NASDAQ:LMRA), a leader in the emerging field of nanotechnology, announced today that it had received a purchase order from Lockheed Martin for Lumera's high electro-optic activity materials. The term of the agreement is until December 31, 2007, at which time Lockheed Martin will advise Lumera of its intentions regarding a commercial license for the materials.
Lumera Receives Order and Enters Into Agreement with Lockheed Martin
BOTHELL, WA | Posted on March 12th, 2007
"We are pleased that Lockheed Martin is interested in our polymer materials and expect that the materials will perform as anticipated," said Dr. Raluca Dinu, Director of Lumera's Electro-Optic Business Unit. "We look forward to developing a long-term relationship with Lockheed Martin."
Lumera is a leader in the emerging field of nanotechnology. The company designs proprietary molecular structures and polymer compounds for the bioscience and communications/computing industries, both of which represent large market opportunities. The company also has developed proprietary processes for fabricating such devices.
Certain statements contained in this release are forward-looking statements that involve a number of risks and uncertainties. Factors that could cause actual results to differ materially from those projected in the company's forward-looking statements include the following: market acceptance of our technologies and products; our ability to obtain financing; our financial and technical resources relative to those of our competitors; our ability to keep up with rapid technological change; government regulation of our technologies; our ability to enforce our intellectual property rights and protect our proprietary technologies; the ability to obtain additional contract awards and to develop partnership opportunities; the timing of commercial product launches; the ability to achieve key technical milestones in key products; and other risk factors identified from time to time in the company's SEC reports, including its Annual Report on Form 10-K, and its Quarterly Reports on Form 10-Q.
For more information, please click here
The Summit Group Communications
Copyright © Business Wire
If you have a comment, please Contact
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Tissue regeneration using anti-inflammatory nanomolecules August 22nd, 2014
A breakthrough in imaging gold nanoparticles to atomic resolution by electron microscopy August 22nd, 2014
Malvern’s Dr Alan Rawle talks TLAs in plenary lecture at Particulate Systems Analysis conference August 21st, 2014
Water window imaging opportunity: A new theoretical study elucidates mechanisms that could help in producing coherent radiations, ultimately promoting high-contrast imaging of biological samples August 21st, 2014
East China University of Science and Technology Purchases Nanonex Advanced Nanoimprint Tool NX-B200 July 30th, 2014
University of Manchester selects Anasys AFM-IR for coatings and corrosion research July 30th, 2014
STFC takes delivery of the 100th Hitachi Tabletop SEM in the UK July 3rd, 2014
University of Maastricht Adds Complete Correlative Workflow from FEI to its Institute of Nanoscopy June 23rd, 2014